Bill Text: NY S00786 | 2025-2026 | General Assembly | Introduced


Bill Title: Provides for education and outreach for drug-induced movement disorders by the department of health through the health care and wellness education and outreach program.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2025-01-13 - ORDERED TO THIRD READING CAL.60 [S00786 Detail]

Download: New_York-2025-S00786-Introduced.html



                STATE OF NEW YORK
        ________________________________________________________________________

                                           786

                               2025-2026 Regular Sessions

                    IN SENATE

                                       (Prefiled)

                                     January 8, 2025
                                       ___________

        Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
          printed to be committed to the Committee on Rules

        AN ACT to amend the public health law, in relation  to  authorizing  the
          health care and wellness education and outreach program to develop and
          disseminate information regarding drug-induced movement disorders

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph (h) of subdivision 1 of section 207 of the public
     2  health law, as added by a chapter of  the  laws  of  2024  amending  the
     3  public  health  law  relating  to  establishing  a drug-induced movement
     4  disorder screening education program, as proposed in  legislative  bills
     5  numbers S. 8965-A and A. 6799-B, is amended to read as follows:
     6    (h)  [The  department  shall  develop and conduct a program concerning
     7  drug-induced]  Drug-induced  movement  disorders[.  Such  program  shall
     8  include  but not be limited to, (i) educational information on], includ-
     9  ing the importance of screening for and identifying symptoms of drug-in-
    10  duced movement disorders[; and (ii) the development and dissemination of
    11  educational materials for healthcare providers regarding], treatment for
    12  drug-induced movement disorders, [including for  services  provided  via
    13  telehealth.   Such] and information on methods by which the stigma expe-
    14  rienced by people living with drug-induced movement disorders related to
    15  the treatment of mental health conditions may be reduced or  eliminated.
    16  Any  such  educational  materials  disseminated  to healthcare providers
    17  shall be developed [and] in consultation with the  commissioner  of  the
    18  office  of mental health, disseminated by the department in coordination
    19  with relevant healthcare provider groups, and shall include  best  prac-
    20  tices  for the treatment and screening of movement disorders informed by
    21  the American Psychiatric  Association  and  other  professional  society
    22  practice  guidelines.    [Such  program shall also include education and
    23  outreach on the elimination of stigma for people  living  with  drug-in-

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02693-01-5

        S. 786                              2

     1  duced  movement  disorders  related  to  the  treatment of mental health
     2  conditions.]
     3    §  2.  This  act  shall  take  effect on the same date and in the same
     4  manner as a chapter of the laws of 2024 amending the public  health  law
     5  relating  to  establishing  a  drug-induced  movement disorder screening
     6  education program, as proposed in legislative bills  numbers  S.  8965-A
     7  and A. 6799-B, takes effect.
feedback